icatibant and Paraproteinemias

icatibant has been researched along with Paraproteinemias* in 1 studies

Other Studies

1 other study(ies) available for icatibant and Paraproteinemias

Article	Year
Clinical and biological response to rituximab treatment in 3 patients with acquired C1-inhibitor deficiency. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2017, Volume: 119, Issue:4 Topics: Aged, 80 and over; Angioedema; Angioedemas, Hereditary; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Bradykinin B2 Receptor Antagonists; Complement C1 Inactivator Proteins; Female; Humans; Immunologic Factors; Lymphoma; Male; Middle Aged; Paraproteinemias; Peptides; Rituximab; Treatment Outcome	2017

Article

Year

Clinical and biological response to rituximab treatment in 3 patients with acquired C1-inhibitor deficiency.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2017, Volume: 119, Issue:4

Topics: Aged, 80 and over; Angioedema; Angioedemas, Hereditary; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Bradykinin B2 Receptor Antagonists; Complement C1 Inactivator Proteins; Female; Humans; Immunologic Factors; Lymphoma; Male; Middle Aged; Paraproteinemias; Peptides; Rituximab; Treatment Outcome

2017